Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Gross Margin (2020 - 2022)

Historic Gross Margin for iBio (IBIO) over the last 4 years, with Q1 2022 value amounting to 105.28%.

  • iBio's Gross Margin rose 697200.0% to 105.28% in Q1 2022 from the same period last year, while for Jun 2022 it was 115.02%, marking a year-over-year increase of 571100.0%. This contributed to the annual value of 115.02% for FY2022, which is 766800.0% up from last year.
  • According to the latest figures from Q1 2022, iBio's Gross Margin is 105.28%, which was up 697200.0% from 203.57% recorded in Q3 2021.
  • In the past 5 years, iBio's Gross Margin registered a high of 203.57% during Q3 2021, and its lowest value of 10.42% during Q1 2020.
  • Moreover, its 3-year median value for Gross Margin was 71.69% (2020), whereas its average is 79.25%.
  • Data for iBio's Gross Margin shows a peak YoY increase of 1296700bps (in 2021) and a maximum YoY decrease of -113900bps (in 2021) over the last 5 years.
  • Over the past 3 years, iBio's Gross Margin (Quarter) stood at 70.07% in 2020, then soared by 191bps to 203.57% in 2021, then plummeted by -48bps to 105.28% in 2022.
  • Its last three reported values are 105.28% in Q1 2022, 203.57% for Q3 2021, and 61.91% during Q2 2021.